semaglutide and visceral fat Diabetes Medication Reduces Excess Body in People With Obesity The Insulin Paradox: How GLP-1

Long-term follow-up of children conceived through assisted reproductive technology

Start your intake Seizure Risk and GLP-1 Medications: What the Evidence Shows Clinical literature on GLP-1 agonists and seizure risk remains limited, but available data is reassuring

The SURPASS program established efficacy in type 2 diabetes across multiple comparators, including head-to-head superiority versus semaglutide on HbA1c reduction in SURPASS-2 (Fras et al., NEJM, 2021)

P., Tchernof, A

Manufactured through controlled production workflows, each lot is handled under internal quality procedures designed to support consistency, documentation, and traceability